Sangamo Therapeutics, Inc.
SGMO
$0.615
-$0.0919-13.00%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 61.20% | 110.25% | 68.45% | -332.29% | -16.01% |
| Total Depreciation and Amortization | -29.05% | -71.33% | -58.38% | -54.74% | -44.69% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -56.87% | -93.42% | -91.89% | -89.67% | -18.62% |
| Change in Net Operating Assets | 1,858.75% | -67.30% | 176.19% | 94.40% | 104.39% |
| Cash from Operations | 93.37% | 124.86% | 55.72% | 26.60% | 11.41% |
| Capital Expenditure | 94.31% | 95.81% | -- | -- | 64.26% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -100.00% | -100.00% | -21.96% | -19.38% |
| Cash from Investing | -96.49% | -99.38% | -99.70% | 0.31% | -11.51% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3,238.43% | -100.00% | -- | 147.22% | -98.90% |
| Repurchase of Common Stock | -348.98% | -100.99% | -174.74% | 63.75% | 65.49% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4,086.23% | -103.00% | -108.18% | 176.46% | -99.15% |
| Foreign Exchange rate Adjustments | -266.08% | 304.73% | -182.11% | -282.56% | 74.58% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 124.02% | 225.19% | -141.41% | 138.86% | -292.54% |
